| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aberrant GPA expression and regulatory function of red blood cells in sickle cell disease
|
Marshall, Juliana N.
|
|
|
8 |
7 |
p. 1687-1697
|
artikel
|
| 2 |
Altered platelet-megakaryocyte endocytosis and trafficking of albumin and fibrinogen in RUNX1 haplodeficiency
|
Del Carpio-Cano, Fabiola
|
|
|
8 |
7 |
p. 1699-1714
|
artikel
|
| 3 |
A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen
|
Karmali, Reem
|
|
|
8 |
7 |
p. 1612-1620
|
artikel
|
| 4 |
A real-world analysis of clinical outcomes in AML with myelodysplasia-related changes: a comparison of ICC and WHO-HAEM5 criteria
|
Zhou, Qianghua
|
|
|
8 |
7 |
p. 1760-1771
|
artikel
|
| 5 |
Biological signatures of the International Prognostic Index in diffuse large B-cell lymphoma
|
Wang, Yue
|
|
|
8 |
7 |
p. 1587-1599
|
artikel
|
| 6 |
Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia
|
Tam, Constantine S.
|
|
|
8 |
7 |
p. 1639-1650
|
artikel
|
| 7 |
CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma
|
Firestone, Ross S.
|
|
|
8 |
7 |
p. 1600-1611
|
artikel
|
| 8 |
Cysteine-binding adjuvant enhances survival and promotes immune function in a murine model of acute myeloid leukemia
|
Slezak, Anna J.
|
|
|
8 |
7 |
p. 1747-1759
|
artikel
|
| 9 |
Deciphering the regulatory landscape of murine splenic response to anemic stress at single-cell resolution
|
Yang, Chong
|
|
|
8 |
7 |
p. 1651-1666
|
artikel
|
| 10 |
Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data
|
Weverling, Flores
|
|
|
8 |
7 |
p. 1683-1686
|
artikel
|
| 11 |
Genetically corrected RAG2-SCID human hematopoietic stem cells restore V(D)J-recombinase and rescue lymphoid deficiency
|
Pavel-Dinu, Mara
|
|
|
8 |
7 |
p. 1820-1833
|
artikel
|
| 12 |
Hemophilia B and gene therapy: a new chapter with etranacogene dezaparvovec
|
Anguela, Xavier M.
|
|
|
8 |
7 |
p. 1796-1803
|
artikel
|
| 13 |
Immunoglobulin replacement vs prophylactic antibiotics for hypogammaglobulinemia secondary to hematological malignancy
|
McQuilten, Zoe K.
|
|
|
8 |
7 |
p. 1787-1795
|
artikel
|
| 14 |
Impact of different genetic mutations on granulocyte development and G-CSF responsiveness in congenital neutropenia
|
Meng, Xin
|
|
|
8 |
7 |
p. 1667-1682
|
artikel
|
| 15 |
Impact of MYC and BCL2 double expression on outcomes in primary CNS lymphoma: a UK multicenter analysis
|
Poynton, Edward
|
|
|
8 |
7 |
p. 1772-1775
|
artikel
|
| 16 |
In vivo measurement of RBC survival in patients with sickle cell disease before or after hematopoietic stem cell transplantation
|
Leonard, Alexis K.
|
|
|
8 |
7 |
p. 1806-1816
|
artikel
|
| 17 |
Long live the red blood cell: biotin tagging in SCD
|
McCuskee, Sarah
|
|
|
8 |
7 |
p. 1804-1805
|
artikel
|
| 18 |
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia
|
Kuter, David J.
|
|
|
8 |
7 |
p. 1715-1724
|
artikel
|
| 19 |
Management of acute breakthrough hemolysis with intensive pegcetacoplan dosing in patients with PNH
|
Griffin, Morag
|
|
|
8 |
7 |
p. 1776-1786
|
artikel
|
| 20 |
Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population
|
Lee, David J.
|
|
|
8 |
7 |
p. 1737-1746
|
artikel
|
| 21 |
Matsui H, Arai Y, Imoto H, et al. Risk factors and appropriate therapeutic strategies for thrombotic microangiopathy after allogeneic HSCT. Blood Adv. 2020;4(13):3169-3179.
|
|
|
|
8 |
7 |
p. 1698
|
artikel
|
| 22 |
Mending RAG2: gene editing for treatment of RAG2 deficiency
|
Hicks, Elizabeth D.
|
|
|
8 |
7 |
p. 1817-1819
|
artikel
|
| 23 |
Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemia
|
Eldfors, Samuli
|
|
|
8 |
7 |
p. 1621-1633
|
artikel
|
| 24 |
Regression of smoldering myeloma with treatment of Gaucher disease
|
Barley, Kevin
|
|
|
8 |
7 |
p. 1634-1638
|
artikel
|
| 25 |
Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2A
|
Seidizadeh, Omid
|
|
|
8 |
7 |
p. 1725-1736
|
artikel
|
Tijdschrift beschrijving